R. E. Lang

725 total citations
23 papers, 587 citations indexed

About

R. E. Lang is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Social Psychology. According to data from OpenAlex, R. E. Lang has authored 23 papers receiving a total of 587 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 6 papers in Molecular Biology and 3 papers in Social Psychology. Recurrent topics in R. E. Lang's work include Stress Responses and Cortisol (3 papers), Neuroendocrine regulation and behavior (3 papers) and Heart Failure Treatment and Management (3 papers). R. E. Lang is often cited by papers focused on Stress Responses and Cortisol (3 papers), Neuroendocrine regulation and behavior (3 papers) and Heart Failure Treatment and Management (3 papers). R. E. Lang collaborates with scholars based in Germany, United States and Sweden. R. E. Lang's co-authors include Detlev Ganten, Wolfgang Rascher, Thomas Unger, Rüdiger von Harsdorf, Elizabeth A. Woodcock, M Fullerton, Friedrich C. Luft, George R. Aronoff, R. Bernd Sterzel and D Ganten and has published in prestigious journals such as Circulation Research, Neuroscience and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

R. E. Lang

21 papers receiving 553 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. E. Lang Germany 12 250 211 133 95 84 23 587
David J. Dzielak United States 13 187 0.7× 124 0.6× 93 0.7× 118 1.2× 21 0.3× 23 584
J. C. Fray United States 19 358 1.4× 350 1.7× 54 0.4× 168 1.8× 53 0.6× 39 768
Michèle Grima France 13 189 0.8× 149 0.7× 35 0.3× 75 0.8× 45 0.5× 34 505
M Böhm Germany 10 535 2.1× 260 1.2× 56 0.4× 169 1.8× 54 0.6× 17 786
Adam S. Budzikowski United States 12 212 0.8× 126 0.6× 42 0.3× 96 1.0× 58 0.7× 53 453
Miroslava Macova United States 8 376 1.5× 223 1.1× 87 0.7× 65 0.7× 78 0.9× 8 710
P. J. Kadowitz United States 13 95 0.4× 119 0.6× 127 1.0× 159 1.7× 33 0.4× 33 498
Seiko Tsuda Japan 13 85 0.3× 192 0.9× 182 1.4× 74 0.8× 22 0.3× 41 407
Daniel Butlen France 16 70 0.3× 394 1.9× 103 0.8× 92 1.0× 296 3.5× 33 799
Laura M. Plunkett United States 16 337 1.3× 325 1.5× 199 1.5× 66 0.7× 109 1.3× 18 627

Countries citing papers authored by R. E. Lang

Since Specialization
Citations

This map shows the geographic impact of R. E. Lang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. E. Lang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. E. Lang more than expected).

Fields of papers citing papers by R. E. Lang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. E. Lang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. E. Lang. The network helps show where R. E. Lang may publish in the future.

Co-authorship network of co-authors of R. E. Lang

This figure shows the co-authorship network connecting the top 25 collaborators of R. E. Lang. A scholar is included among the top collaborators of R. E. Lang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. E. Lang. R. E. Lang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mao, Ke, Bingqing Wang, Hao Zhu, et al.. (2025). Deciphering TCOF1 mutations in Chinese Treacher Collins syndrome patients: insights into pathogenesis and transcriptional disruption. Orphanet Journal of Rare Diseases. 20(1). 57–57. 1 indexed citations
2.
Lettgen, B., et al.. (1994). Elevated plasma concentration of neuropeptide Y in adolescents with primary hypertension.. PubMed. 8(5). 345–9. 21 indexed citations
3.
Lang, R. E., et al.. (1990). A Possible Linkage of Atrial Natriuretic Peptide to the Immune System. American Journal of Hypertension. 3(5 Pt 1). 408–411. 3 indexed citations
4.
Harsdorf, Rüdiger von, R. E. Lang, M Fullerton, & Elizabeth A. Woodcock. (1989). Myocardial stretch stimulates phosphatidylinositol turnover.. Circulation Research. 65(2). 494–501. 73 indexed citations
6.
Luft, Friedrich C., H. Steinberg, Ursula Ganten, et al.. (1988). Effect of sodium chloride and sodium bicarbonate on blood pressure in stroke-prone spontaneously hypertensive rats. Clinical Science. 74(6). 577–585. 52 indexed citations
8.
Lang, R. E., et al.. (1988). Endothelin stimulates atrial natriuretic peptide (ANP) release from rat atria. European Journal of Pharmacology. 158(1-2). 177–178. 69 indexed citations
9.
Weil, J., Tim M. Strom, J Heim, et al.. (1988). Influence of diurnal rhythm, posture and right atrial size on plasma atrial natriuretic peptide levels.. PubMed. 77 Suppl 2. 36–40. 12 indexed citations
10.
Weil, Joachim, K Bühlmeyer, C Döhlemann, et al.. (1986). Atrial Natriuretic Peptide in Healthy Children from Birth to Adolescence and in Children with Cardiac Diseases. Journal of Cardiovascular Pharmacology. 8(6). 1300–1300. 4 indexed citations
11.
Suzuki, Hiromichi, Takao Saruta, Kazuoki Kondo, et al.. (1986). Central and Peripheral Contributions of the Renin-Angiotensin System in Two Models Experimental Hypertension in Rats. Clinical and Experimental Hypertension Part A Theory and Practice. 8(1). 113–128. 4 indexed citations
12.
Gnädinger, Markus, et al.. (1986). Plasma kinetics of synthetic alpha-human atrial natriuretic peptide in man.. PubMed. 12(5-6). 371–4. 28 indexed citations
13.
Weil, J., F. Bidlingmaier, C Döhlemann, et al.. (1986). Plasma atrial natriuretic peptide concentrations during intracardiac pacing. European Journal of Endocrinology. 113(1_Suppl). S164–S165. 4 indexed citations
14.
Heym, Ch. & R. E. Lang. (1985). Differences in the immunohistochemistry of biogenic polypeptides in paraganglionic cell populations in sympathetic ganglia. European Journal of Endocrinology. 110(1_Suppla). S66–S67. 3 indexed citations
15.
Lang, R. E., et al.. (1983). [Effect of co-dergocrine mesylate on catecholamines and prolactin in elderly hypertensive patients].. PubMed. 33(5). 771–3. 1 indexed citations
16.
Rascher, Wolfgang, R. E. Lang, T Unger, Detlev Ganten, & F. Gross. (1982). Vasopressin in brain of spontaneously hypertensive rats. American Journal of Physiology-Heart and Circulatory Physiology. 242(4). H496–H499. 44 indexed citations
17.
Rascher, Wolfgang, R. E. Lang, Bruno Fink, et al.. (1982). Reduced Synthesis of [Arginine]Vasopressin in Spontaneously Hypertensive Rats. Clinical Science. 63(s8). 117s–119s. 6 indexed citations
18.
Yukimura, Tokihito, Thomas Unger, Wolfgang Rascher, R. E. Lang, & Detlev Ganten. (1981). Central Peptidergic Stimulation in Blood Pressure Control: Role of Enkephalins in Rats. Clinical Science. 61(s7). 347s–350s. 27 indexed citations
19.
Lang, R. E.. (1980). Brain and pituitary peptides. Molecular and Cellular Endocrinology. 20(1). 99–100. 87 indexed citations
20.
Fehm, HL, K. H. Voigt, R. E. Lang, & E. F. Pfeiffer. (1974). No ‘Ultra-Short Feedback Mechanism’ for ACTH. Neuroendocrinology. 16(5-6). 364–368. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026